EDGAR Filing Documents for 0001104659-17-018638

Form 8-K - Current report:

SEC Accession No. 0001104659-17-018638

Filing Date

2017-03-22

Accepted

2017-03-22 17:25:20

Documents

Period of Report

2017-03-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-9004_18k.htm	8-K	39518
2	EX-1.1	a17-9004_1ex1d1.htm	EX-1.1	337738
3	EX-5.1	a17-9004_1ex5d1.htm	EX-5.1	59216
4	EX-99.1	a17-9004_1ex99d1.htm	EX-99.1	13226
5	EX-99.2	a17-9004_1ex99d2.htm	EX-99.2	13636
6	GRAPHIC	g90041mmi001.jpg	GRAPHIC	5112
7	GRAPHIC	g90041moi001.jpg	GRAPHIC	5112
	Complete submission text file	0001104659-17-018638.txt		479011

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY

Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000

Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)